Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-24

Clinical Trial Update: Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

View source ↗

Summary

A completed study reports the incidence of relapse and Post-kala-azar dermal leishmaniasis in South Sudan among visceral leishmaniasis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Epicentre | Conditions: Leishmaniasis, Leishmaniasis, Visceral | Status: COMPLETED